ArticleJournal of hepatocellular carcinoma2026
Development and Validation of a Nomogram for Predicting Response to TACE Combined with Lenvatinib and Anti-PD-1 Therapy in Unresectable Hepatocellular Carcinoma.
Ying Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.